Return to search

Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease

Nicotinamide delivered in drinking water at about 2 g/kg/day significantly prolonged survival and showed a suggestive improvement on memory in the Npc1 (nih) / Npc1 (nih) mouse model of infantile NPC1 disease. It is likely that this role is due to its function as a histone deacetylase (HDAC) inhibitor although another HDAC inhibitor, valproic acid, was without effect. Nicotinamide could also work by preventing/reversing oxidative stress.

Identiferoai:union.ndltd.org:arizona.edu/oai:arizona.openrepository.com:10150/622828
Date25 October 2016
CreatorsMarshall, Craig A., Borbon, Ivan A., Erickson, Robert P.
ContributorsDepartment of Pediatrics, University of Arizona
PublisherSPRINGER HEIDELBERG
Source SetsUniversity of Arizona
LanguageEnglish
Detected LanguageEnglish
TypeArticle
Rights© Institute of Plant Genetics, Polish Academy of Sciences, Poznan 2016
Relationhttp://link.springer.com/10.1007/s13353-016-0367-0

Page generated in 0.0013 seconds